Singh S, Singh M, Mak I, Ghert M
Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Open Orthop J. 2013 May 3;7:109-13. doi: 10.2174/1874325001307010109. Print 2013.
Giant cell tumor of bone in a neoplastic stromal cell which survives for multiple passages in primary cell culture with a stable phenotype. In the pathological environment of GCT, the neoplastic nature of the mesenchymal stromal component drives local hematopoietic precursors to undergo fusion and form multinucleated osteoclast like giant cells. There is currently very limited knowledge about the pathogenesis of GCT due to the lack of suitable in vivo models for this tumor. Here we report stable gene transfer of Green fluorescence protein (GFP) in GCT stromal cells. In the present study, we have used GCT stromal cells that stably express enhanced green fluorescence protein (GFP) that are used in a new in vivo culture model. Our results show the utility of the GFP tagged cell lines that stably express GFP signals up to 52 weeks of continuous growth. The in vivo model described herein can serve as an excellent system for in vivo therapeutic and mechanistic evaluation of existing and novel targets for GCT.
骨巨细胞瘤中的肿瘤性基质细胞在原代细胞培养中可多次传代且表型稳定。在骨巨细胞瘤的病理环境中,间充质基质成分的肿瘤性质驱使局部造血前体细胞发生融合并形成多核破骨细胞样巨细胞。由于缺乏适合该肿瘤的体内模型,目前关于骨巨细胞瘤发病机制的了解非常有限。在此我们报道绿色荧光蛋白(GFP)在骨巨细胞瘤基质细胞中的稳定基因转移。在本研究中,我们使用了稳定表达增强型绿色荧光蛋白(GFP)的骨巨细胞瘤基质细胞,并将其用于一种新的体内培养模型。我们的结果表明,绿色荧光蛋白标记的细胞系在持续生长达52周时仍能稳定表达绿色荧光蛋白信号。本文所述的体内模型可作为一个出色的系统,用于对骨巨细胞瘤现有和新靶点进行体内治疗和机制评估。